Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.6207delG | p.Lys2069AsnfsX19 | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
AAG | Lys | del1c | Fs. | Stop at 2087 | Fr. |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
TGFBP#06 | C-Term MMPs site |
At the mRNA level | On restriction map |
No mechanism suspected | New restriction site(s): none Lost restriction site(s): none |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
FRA01BOU F0327 I0365 | Proband | Female | de novo | FRANCE |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
Reference ID | PubMed ID | Reference |
145 | 19293843 | Stheneur C, Collod-B*roud G, Faivre L, Buyck JF, Gouya L, Le Parc JM, Moura B, Muti C, Grandchamp B, Sultan G, Claustres M, Aegerter P, Chevallier B, Jondeau G, Boileau C. "Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene". Eur J Hum Genet. 2009 Sep;17(9):1121-8. |